New hope for glioblastoma treatment emerging in research in Slovenia
Ljubljana, 3 September - Researchers at the National Institute of Biology are exploring new avenues for more effective treatment of glioblastoma, the most aggressive form of brain cancer. Having discovered different biomarkers that could be used as drug targets, the team will present their groundbreaking findings at an international conference held from 4 to 6 September.
Ljubljana.
3D models of tumours in an incubator at the National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Tumour cell culture in a lab at the National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
Ljubljana.
Interview with Barbara Breznik, Head of the Cancer Biology Group at National Institute of Biology.
Photo: Bor Slana/STA
The rest of this news item is available to subscribers.
The news item consists of 4.892 characters (without spaces) or 842 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.